Clindamycin as adjuvant therapy in Staphilococcal skin scalded syndrome
DOI:
https://doi.org/10.23938/ASSN.0330Keywords:
Staphylococcal skin syndrome. Staphylococcus aureus. Clindamycin.Abstract
Staphylococcal scalded skin syndrome (SSSS) is a dermatologic disease caused by exotoxins produced by Staphylococcus aureus. The disease presents as a painful cutaneous rash that culminates with the detachment of the superficial dermis. The usual treatment is antibiotics with beta-lactamase resistant penicillin. We report the case of a patient who presented with SSSS with initial torpid evolution despite antibiotic treatment and after the introduction of clindamycin IV experienced a very significant improvement. Concerns about the increase of methicillin resistant Staphylococcus aureus (MRSA) and the pathophysiology of this disease make bacteriostatic spectrum antistaphylococcal antibiotics, such as clindamycin, strong candidates for consideration as a first-line therapeutic arsenal for the treatment of SSSS.
Downloads
References
1. BUKOWSKI M, WLADYKA B, DUBIN G. Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) 2010; 2: 1148-1165.
https://doi.org/10.3390/toxins2051148
2. PATEL GK, FINLAY AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 2003; 4: 165-175.
https://doi.org/10.2165/00128071-200304030-00003
3. MOCKENHAUPT M, IDZKO M, GROSBER M, SCHOPF E, NORGAUER J. Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol 2005; 124: 700-703.
https://doi.org/10.1111/j.0022-202X.2005.23642.x
4. LAMAND V, DAUWALDER O, TRISTAN A, CASALEGNO JS, MEUGNIER H, BES M et al. Epidemiological data of staphylococcal scalded skin syndrome in France from 1997 to 2007 and microbiological characteristics of Staphylococcus aureus associated strains. Clin Microbiol Infect 2012; 18: E514-521.
https://doi.org/10.1111/1469-0691.12053
5. NSO ROCA AP, BAQUERO-ARTIGAO F, GARCÍA-MIGUEL MJ, DE JOSÉ GÓMEZ MI, ARACIL SANTOS FJ, DEL CASTILLO MARTÍN F. Staphylococcal scalded skin syndrome. An Pediatr (Barc) 2008; 68: 124-127.
https://doi.org/10.1157/13116226
6. HANDLER MZ, SCHWARTZ RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol 2014 20. doi: 10.1111/jdv.12541.
https://doi.org/10.1111/jdv.12541
7. COURJON J, HUBICHE T, PHAN A, TRISTAN A, BÈS M, VANDENESCH F et al. Skin findings of Staphylococcus aureus toxin-mediated infection in relation to toxin encoding genes. Pediatr Infect Dis J 2013; 32: 727-730.
https://doi.org/10.1097/INF.0b013e31828e89f5
8. LAPPIN E, FERGUSON AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis 2009; 9: 281-290.
https://doi.org/10.1016/S1473-3099(09)70066-0
9. BRAUNSTEIN I, WANAT KA, ABUABARA K, MCGOWAN KL, YAN AC, TREAT JR. Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome. Pediatr Dermatol 2013 23. doi: 10.1111/pde.12195
https://doi.org/10.1111/pde.12195
10. STEVENS DL, MA Y, SALMI DB, MCINDOO E, WALLACE RJ, BRYANT AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007; 195: 202-211.
https://doi.org/10.1086/510396
11. LIPOVÝ B1, BRYCHTA P, CHALOUPKOVÁ Z, SUCHÁNEK I. Staphylococcal scalded skin syndrome in the Czech Republic: an epidemiological study. Burns 2012; 38: 296-300.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
